Hanmi Pharm. Co., Ltd. (KRX:128940)

Hanmi Pharm. Statistics

Total Valuation

Hanmi Pharm. has a market cap or net worth of KRW 5.62 trillion. The enterprise value is 6.03 trillion.

Market Cap	5.62T
Enterprise Value	6.03T

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Hanmi Pharm. has 12.68 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	12.68M
Shares Outstanding	12.68M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.81%
Owned by Institutions (%)	19.56%
Float	6.20M

Valuation Ratios

The trailing PE ratio is 42.70 and the forward PE ratio is 32.54. Hanmi Pharm.'s PEG ratio is 1.53.

PE Ratio	42.70
Forward PE	32.54
PS Ratio	3.76
PB Ratio	4.18
P/TBV Ratio	4.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.53

Enterprise Valuation

EV / Earnings	39.16
EV / Sales	4.03
EV / EBITDA	n/a
EV / EBIT	26.40
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.40

Current Ratio	1.40
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 11.64% and return on invested capital (ROIC) is 9.07%.

Return on Equity (ROE)	11.64%
Return on Assets (ROA)	7.00%
Return on Invested Capital (ROIC)	9.07%
Return on Capital Employed (ROCE)	15.69%
Revenue Per Employee	623.21M
Profits Per Employee	64.13M
Employee Count	2,400
Asset Turnover	0.75
Inventory Turnover	n/a

Taxes

In the past 12 months, Hanmi Pharm. has paid 31.30 billion in taxes.

Income Tax	31.30B
Effective Tax Rate	16.90%

Stock Price Statistics

The stock price has increased by +31.80% in the last 52 weeks. The beta is 0.50, so Hanmi Pharm.'s price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+31.80%
50-Day Moving Average	347,800.00
200-Day Moving Average	287,962.50
Relative Strength Index (RSI)	66.56
Average Volume (20 Days)	212,659

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hanmi Pharm. had revenue of KRW 1.50 trillion and earned 153.90 billion in profits. Earnings per share was 10,387.45.

Revenue	1.50T
Gross Profit	823.80B
Operating Income	228.30B
Pretax Income	185.20B
Net Income	153.90B
EBITDA	n/a
EBIT	228.30B
Earnings Per Share (EPS)	10,387.45

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	1.35T
Book Value Per Share	106,125.97
Working Capital	234.50B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 55.08%, with operating and profit margins of 15.26% and 10.29%.

Gross Margin	55.08%
Operating Margin	15.26%
Pretax Margin	12.38%
Profit Margin	10.29%
EBITDA Margin	n/a
EBIT Margin	15.26%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1,250.00, which amounts to a dividend yield of 0.27%.

Dividend Per Share	1,250.00
Dividend Yield	0.27%
Dividend Growth (YoY)	150.00%
Years of Dividend Growth	7
Payout Ratio	n/a
Buyback Yield	0.03%
Shareholder Yield	0.30%
Earnings Yield	2.74%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.02

Scores

Altman Z-Score	n/a
Piotroski F-Score	3